MoneyWorks4Me

Astal Laboratories - Quaterly Results

12 Aug 2025 Evaluate
An increase of about 92.66% to Rs. 253.27 millions in the topline was observed for the quarter ended June 2025. The topline stood at Rs. 131.46 millions during the similar quarter previous year.Net profit stood at Rs. 20.90  millions  compared to Rs. 16.89 millions in the corresponding previous quarter,high by 23.74%.Operating profit for the quarter ended June 2025 rose to 32.14 millions as compared to 24.14 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 253.27 131.46 92.66 253.27 131.46 92.66 642.31 236.48 171.61
Other Income 0.56 0.34 64.71 0.56 0.34 64.71 1.25 0.13 861.54
PBIDT 32.14 24.14 33.14 32.14 24.14 33.14 129.02 11.28 1043.79
Interest 3.01 0.63 377.78 3.01 0.63 377.78 7.01 0.11 6272.73
PBDT 29.13 23.51 23.90 29.13 23.51 23.90 122.01 11.17 992.30
Depreciation 1.20 0.13 823.08 1.20 0.13 823.08 2.23 0.30 643.33
PBT 27.93 23.38 19.46 27.93 23.38 19.46 119.78 10.87 1001.93
TAX 7.03 6.49 8.32 7.03 6.49 8.32 30.52 3.02 910.60
Deferred Tax 2.47 0.26 850.00 2.47 0.26 850.00 1.11 0.08 1287.50
PAT 20.90 16.89 23.74 20.90 16.89 23.74 89.26 7.85 1037.07
Equity 98.46 98.46 0.00 98.46 98.46 0.00 98.46 98.46 0.00
PBIDTM(%) 12.69 18.36 -30.89 12.69 18.36 -30.89 20.09 4.77 321.11
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..